Physician profile
Hysoo Ka-Widmann
NPI 1841385259
$5,389.27
in general payments reported to CMS, 2019-2025
50 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $286 · 2021: $609 · 2022: $1,056 · 2023: $971 · 2024: $727 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,768.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,056.66 | 2019-2025 | |
| Hologic Sales and Service, LLC | $830.30 | 2019-2025 | Coolseal Generator, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $494.24 | 2021-2025 | |
| Pfizer INC. | $318.74 | 2019-2025 | |
| Astellas Pharma US INC | $286.51 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $228.57 | 2021-2025 | Slynd |
| Organon LLC | $192.76 | 2024-2025 | Nexplanon |
| Aspira Women'S Health INC | $182.35 | 2021-2022 | |
| Therapeuticsmd, INC. | $135.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.51 | 2019-2025 | |
| Millicent US INC | $110.75 | 2024-2025 | Intrarosa, Femlyv |
| Allergan, INC. | $103.82 | 2019-2020 | |
| Coopersurgical, INC. | $85.73 | 2019-2025 | Paragard T 380a |
| Shield Therapeutics INC | $72.18 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $66.57 | 2023-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $63.18 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $61.03 | 2023-2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $59.46 | 2021-2022 | |
| Channel Medsystems, INC. | $57.49 | 2021-2023 | |
| Becton, Dickinson and Company | $57.23 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $52.96 | 2019 | |
| Merck Sharp & Dohme LLC | $51.63 | 2020-2022 | |
| Roche Diagnostics Corporation | $49.06 | 2019 | |
| Baxter Healthcare | $42.74 | 2024-2025 | Perclot, Tisseel |
| Boston Scientific Corporation | $39.88 | 2024-2025 | Bulkamid |
| Biogen, INC. | $39.86 | 2025 | Zurzuvae |
| Gynesonics, INC. | $39.65 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $34.80 | 2019-2023 | Balcoltra |
| Scynexis, INC. | $34.72 | 2022 | |
| Exact Sciences Corporation | $34.49 | 2025 | The Cologuard Plus Collection Kit |
| Olympus America INC. | $34.37 | 2019-2025 | Olympus |
| Evofem Biosciences, INC. | $25.51 | 2022 | |
| Agile Therapeutics, INC. | $24.90 | 2022 | |
| Acera Surgical, INC. | $23.83 | 2025 | Restrata Wound Matrix |
| Hologic INC | $23.52 | 2021 | |
| Axonics, INC. | $23.10 | 2023 | Bulkamid, Axonics |
| Daiichi Sankyo INC. | $22.75 | 2019 | |
| Meditrina | $22.67 | 2023 | |
| Momentis Surgical INC. | $22.00 | 2022 | |
| Amgen INC. | $19.29 | 2025 | Evenity |
| Innovation Technologies INC | $18.71 | 2025 | Irrisept |
| Ethicon US, LLC | $18.33 | 2024 | Ethicon |
| Lilly USA, LLC | $16.56 | 2019 | |
| Molnlycke Health Care US, LLC | $16.06 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Smith+Nephew, INC. | $15.93 | 2019 | |
| Duchesnay USA Incorporated | $14.93 | 2019 | |
| Acessa Health INC. | $14.83 | 2020 | |
| Lupin INC. | $12.97 | 2019 | |
| Dysis Medical, INC. | $12.25 | 2020 | |
| Bard Access Systems, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hysoo Ka-Widmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.